However, there were also situations in which the transfection of EVs with Smad2/3 siRNA had a better effect, amplifying the ability of ADSCs or MSCs to regress endothelial dysfunction or even the administration as such of Smad2/3 siRNA had a better effect. This evidence concerns the gene SMAD2 and endothelial dysfunction.